Losartan protects human stem cell-derived cardiomyocytes from angiotensin II-induced alcoholic cardiotoxicity
Abstract Alcoholic cardiomyopathy (ACM) is a myocardial injury caused by long-term heavy drinking. Existing evidence indicates that high levels of oxidative stress are the key to pathological cardiomyopathy caused by long-term exposure to high concentrations of alcohol, while angiotensin II (AngII)...
Main Authors: | Yuanxiu Song, Hongxia Li, Shuhong Ma, Min Zhu, Wen-jing Lu, Feng Lan, Ming Cui |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2022-03-01
|
Series: | Cell Death Discovery |
Online Access: | https://doi.org/10.1038/s41420-022-00945-2 |
Similar Items
-
The losartan renal protection study — rationale, study design and baseline characteristics of RENAAL (Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan)
by: Barry M Brenner, et al.
Published: (2000-12-01) -
Cardiotoxicity of Antineoplastic Therapies and Applications of Induced Pluripotent Stem Cell-Derived Cardiomyocytes
by: Mo-Fan Huang, et al.
Published: (2021-10-01) -
Evaluation of the cardiotoxicity of mitragynine and its analogues using human induced pluripotent stem cell-derived cardiomyocytes.
by: Jun Lu, et al.
Published: (2014-01-01) -
Unveiling Angiotensin II and Losartan-Induced Gene Regulatory Networks Using Human Urine-Derived Podocytes
by: Chantelle Thimm, et al.
Published: (2023-06-01) -
Losartan, an angiotensin-II type 1 receptor blocker, attenuates the liver fibrosis development of non-alcoholic steatohepatitis in the rat
by: Kawaratani Hideto, et al.
Published: (2009-05-01)